Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt flag Egypt · Delayed Price · Currency is EGP
4.510
-0.020 (-0.44%)
At close: Feb 26, 2026
44.88%
Market Cap 9.02B
Revenue (ttm) 3.95B
Net Income (ttm) 397.61M
Shares Out 2.00B
EPS (ttm) 0.20
PE Ratio 22.72
Forward PE 13.32
Dividend 0.04 (0.89%)
Ex-Dividend Date n/a
Volume 16,557,630
Average Volume 39,296,630
Open 4.530
Previous Close 4.530
Day's Range 4.360 - 4.600
52-Week Range 3.022 - 4.810
Beta 0.13
RSI 74.74
Earnings Date Mar 8, 2026

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol RMDA
Full Company Profile

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.

Financial Statements

News

There is no news available yet.